Lotus Clinical Research is a specialized CRO in CNS and Metabolic research across all phases of drug development. With science always guiding us, we are an extension of your team, providing the expertise and insights to move your studies forward. Through our wholly-owned network of sites which includes state-of-the-art Phase 1 facilities, we have unparalleled access to patients across the CNS and Metabolic disease spectrum. Specializing in obesity, diabetes, MASH, endocrinology, renal and hepatic impairment, pain, sleep, psychiatry, and addiction, our comprehensive clinical development services and in-house experts can help streamline and fast-track your next clinical study.
2014